Associated Papers
Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions.
Lee KJ et al.
Journal of Stroke, 2026
Association between two single nucleotide polymorphisms of the Prostaglandin-Endoperoxide Synthase 1 and 2 genes and cell proliferative prostatic diseases in Lebanon.
Sheehan BJ et al.
Oncotarget, 2025
Genetic factors related to aspirin resistance using the Multiplate® device in Hong Kong Chinese patients with stable coronary heart disease.
Zeng W et al.
Heliyon, 2024
Impact of pharmacogenetics on aspirin resistance: a systematic review.
Silva GFD et al.
Arquivos De Neuro-psiquiatria, 2023
Molecular monitoring of patient response to painkiller drugs.
Ayuso P et al.
Expert Review of Molecular Diagnostics, 2022
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients.
Hirata TDC et al.
Molecular Diagnosis & Therapy, 2021
Effect of 106PEAR1 and 168PTGS1 genetic polymorphisms on recurrent ischemic stroke in Chinese patient.
Zhao J et al.
Medicine, 2019
Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction.
Pandey CP et al.
The Indian Journal of Medical Research, 2019
COX-1 and COX-2 polymorphisms in susceptibility to cerebral palsy in very preterm infants.
Kapitanović Vidak H et al.
Molecular Neurobiology, 2017
Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Zaiou M et al.
Clinical Genetics, 2017
Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.
Sionova M et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology, 2017
Use of genetic data to guide therapy in arterial disease.
Ross S et al.
Journal of Thrombosis and Haemostasis : Jth, 2015
Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.
Gao LC et al.
European Journal of Clinical Pharmacology, 2015
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction.
Verschuren JJ et al.
International Journal of Cardiology, 2013
Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.
Kraus S et al.
Pharmacogenetics and Genomics, 2013
Expanding role of pharmacogenomics in the management of cardiovascular disorders.
Yip VL et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions, 2013
Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.
Tantry US et al.
Expert Review of Cardiovascular Therapy, 2013
Aspirin resistance: clinical significance and genetic polymorphism.
Xu ZH et al.
The Journal of International Medical Research, 2012
Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk.
Frank B et al.
International Journal of Cancer, 2010
Platelet gene polymorphisms and risk of bleeding in patients undergoing elective coronary angiography: a genetic substudy of the PRAGUE-8 trial.
Motovska Z et al.
Atherosclerosis, 2010
Platelet pharmacogenomics.
Zuern CS et al.
Journal of Thrombosis and Haemostasis : Jth, 2010
Platelet glycoprotein GP VI 13254C allele is an independent risk factor of premature myocardial infarction.
Motovska Z et al.
Thrombosis Research, 2010
Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
Gong Z et al.
International Journal of Colorectal Disease, 2009
Pharmacogenetics of aspirin resistance: a comprehensive systematic review.
Goodman T et al.
British Journal of Clinical Pharmacology, 2008
Dose-related efficacy of aspirin after coronary surgery in patients With Pl(A2) polymorphism (NCT00262275).
Lim E et al.
The Annals of Thoracic Surgery, 2007
Effect of a specific cyclooxygenase-gene polymorphism (A-842G/C50T) on the occurrence of peptic ulcer hemorrhage.
van Oijen MG et al.
Digestive Diseases and Sciences, 2006
Cyclooxygenase-1 haplotype modulates platelet response to aspirin.
Maree AO et al.
Journal of Thrombosis and Haemostasis : Jth, 2005
Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy.
Shi J et al.
The European Respiratory Journal, 2005
Structural and catalytic polymorphism of human enzymes: Novel potential platforms for biomedical diagnostics.
Kurova VS et al.
Biotechnology Advances, 0
The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients.
Chakroun T et al.
Genetic Testing and Molecular Biomarkers, 0